Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
41.88
+1.46 (3.61%)
At close: May 12, 2025, 4:00 PM
40.27
-1.61 (-3.84%)
After-hours: May 12, 2025, 6:03 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $7.80 billion as of May 12, 2025. Its market cap has increased by 33.09% in one year.
Market Cap
7.80B
Enterprise Value
5.89B
1-Year Change
33.09%
Ranking
Category
Stock Price
$41.88
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $7.80B, an increase of 374.37%. That is a compound annual growth rate of 34.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 7.53B | -6.85% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |